DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

DEEP vs SUDARSHAN: Stock Comparison

DEEP vs SUDARSHAN PHARMA INDUpdated 18 Sept 26, 4:08 PM ISTNSE & company filings

Metric snapshot

DEEP leads 1; SUDARSHAN leads 2 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DEEPSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹100 Cr
₹0 Cr
P/E RatioSame reading
—
28.27x
P/B RatioSame reading
—
4.11x
EPSDEEP has the higher reading
₹0.9 ✓
₹0.32
Book ValueContext only
₹43.45
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

EPS
DEEP has higher earnings per share
₹0.9 vs ₹0.32
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs -2.73%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs 13.16%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricDEEPSUDARSHAN
Live Price₹46.72₹32.71
Day Change-1.08%0.03%
Volume24,42992,985
52-Week High₹49.17₹39.3
52-Week Low₹34.2₹31.01
Distance from 52W High-4.98%-16.77%

Valuation

MetricDEEPSUDARSHAN
Market Cap₹100 Cr₹0 Cr
P/E Ratio—28.27x
P/B Ratio—4.11x
EPS₹0.9₹0.32
Book Value₹43.45₹6.14
Dividend Yield0%0%

Growth

MetricDEEPSUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-2.73%24.4%
Qtr Profit Growth13.16%38.7%

Profitability & Leverage

MetricDEEPSUDARSHAN
Net Margin0%0%

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDEEPSUDARSHAN
Promoter Holding65.88%▲ 0.04 pp57.81%▼ 1.12 pp
FII Holding0.03%21.95%▲ 2.57 pp
DII Holding—0%
Public Holding34.08%▼ 0.04 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DEEP and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.